Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Corvus Pharmaceuticals
CRVS
$1.17B
| $2.97M | ﹤0.01% |
563,009
+102,869
| +22% | +$369K |
|
3002
Outdoor Holding Co
POWW
$247M
| $2.96M | ﹤0.01% |
2,067,360
-53,214
| -3% | -$84.3K |
|
3003
Lifecore Biomedical
LFCR
$190M
| $2.95M | ﹤0.01% |
597,685
+55,703
| +10% | +$291K |
|
3004
MoonLake Immunotherapeutics
MLTX
$1.55B
| $2.95M | ﹤0.01% |
58,410
-90
| -0.2% | -$4.22K |
|
3005
Abeona Therapeutics
ABEO
$413M
| $2.94M | ﹤0.01% |
465,317
+83,050
| +22% | +$434K |
|
|
SCPH
3006
DELISTED
scPharmaceuticals
SCPH
| $2.93M | ﹤0.01% |
643,342
+61,582
| +11% | +$298K |
|
3007
1stdibs.com
DIBS
$171M
| $2.93M | ﹤0.01% |
664,078
+95,292
| +17% | +$430K |
|
3008
InfuSystem Holdings
INFU
$249M
| $2.92M | ﹤0.01% |
436,508
+7,550
| +2% | +$48.9K |
|
3009
Orchestra BioMed
OBIO
$254M
| $2.92M | ﹤0.01% |
567,219
+11,002
| +2% | +$71.9K |
|
3010
Plains GP Holdings
PAGP
$4.9B
| $2.9M | ﹤0.01% |
156,635
+3,582
| +2% | +$68K |
|
3011
Bitdeer Technologies
BTDR
$2.65B
| $2.89M | ﹤0.01% |
368,564
+46,968
| +15% | +$390K |
|
3012
GrowGeneration
GRWG
$90.7M
| $2.88M | ﹤0.01% |
1,351,699
-26,290
| -2% | -$56.4K |
|
|
KWY
3013
Kingsway Corp
KWY
$293M
| $2.88M | ﹤0.01% |
347,235
+6,941
| +2% | +$56.3K |
|
|
KG
3014
Kestrel Group
KG
$69M
| $2.85M | ﹤0.01% |
80,360
-16,916
| -17% | -$613K |
|
3015
Stereotaxis
STXS
$141M
| $2.84M | ﹤0.01% |
1,391,718
+93,253
| +7% | +$188K |
|
3016
Rigetti Computing
RGTI
$5.99B
| $2.84M | ﹤0.01% |
3,621,829
+617,506
| +21% | +$564K |
|
3017
Townsquare Media
TSQ
$118M
| $2.83M | ﹤0.01% |
278,985
+1,151
| +0.4% | +$12.3K |
|
3018
Quest Resource Holding
QRHC
$31.6M
| $2.81M | ﹤0.01% |
352,670
+3,731
| +1% | +$31.8K |
|
|
GBIO
3019
DELISTED
Generation Bio
GBIO
| $2.81M | ﹤0.01% |
113,917
+326
| +0.3% | +$8.62K |
|
3020
Ispire Technology
ISPR
$98.2M
| $2.81M | ﹤0.01% |
452,444
+197,132
| +77% | +$1.42M |
|
3021
Paysign
PAYS
$705M
| $2.8M | ﹤0.01% |
761,931
-1,478
| -0.2% | -$6.73K |
|
3022
TORM
TRMD
$3.02B
| $2.79M | ﹤0.01% |
81,626
+505
| +0.6% | +$18.5K |
|
|
AY
3023
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.78M | ﹤0.01% |
126,495
-375
| -0.3% | -$8.26K |
|
3024
Sky Harbour Group
SKYH
$386M
| $2.78M | ﹤0.01% |
251,465
+6,887
| +3% | +$73.5K |
|
3025
Biglari Holdings Class B
BH
$1.21B
| $2.76M | ﹤0.01% |
16,039
-84
| -0.5% | -$15.3K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.